Tag: immune-related adverse events in cancer therapy

In recent years, the advent of immune checkpoint inhibitors, such as PD-1 and PD-L1 inhibitors, has revolutionized cancer therapy, offering ...

In a groundbreaking study published in BMC Cancer, researchers have made strides in understanding and predicting liver injury induced by ...

In the relentless battle against lung cancer, a formidable adversary that continues to claim more lives worldwide than any other ...

Immune checkpoint inhibitors (ICIs) have rapidly transformed the landscape of oncology by harnessing the body's immune system to combat malignancies. ...